Insider Transactions in Q1 2024 at Kronos Bio, Inc. (KRON)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 21
2024
|
Elizabeth A Olek SR VP, CLINICAL SCIENCE |
SELL
Open market or private sale
|
Direct |
7,368
-3.67%
|
$7,368
$1.05 P/Share
|
|
Feb 21
2024
|
Allison Frisbee Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
12,105
-5.59%
|
$12,105
$1.05 P/Share
|
|
Feb 21
2024
|
Charles Y Lin Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
12,036
-4.88%
|
$12,036
$1.05 P/Share
|
|
Feb 15
2024
|
Norbert W Bischofberger PRESIDENT & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
270,339
+8.77%
|
-
|
|
Jan 04
2024
|
Christopher Dinsmore Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
7,366
-2.75%
|
$7,366
$1.18 P/Share
|
|
Jan 04
2024
|
Barbara Kosacz COO & General Counsel |
SELL
Open market or private sale
|
Direct |
10,676
-1.14%
|
$10,676
$1.18 P/Share
|
|
Jan 04
2024
|
Jorge Di Martino Chief Medical Officer & VP |
SELL
Open market or private sale
|
Direct |
12,009
-3.67%
|
$12,009
$1.18 P/Share
|